Regulated Information
Financial Reports
SEC Filings
Filter
Filing Date
Form
Description
Filing Group
Downloads
August 4, 2021
6-K
Celyad Oncology Reports First Half 2021 Financial Results And Recent Business Highlights
July 21, 2021
6-K
Celyad Oncology Presents Updates on Allogeneic CAR T Clinical Candidates and shRNA-based Preclinical Concepts at Research & Development Day
June 11, 2021
6-K
Celyad Oncology Presents Preliminary Data From Phase 1 IMMUNICY-1 Trial Of ShRNA-Based Allogeneic CAR T Candidate CYAD-211 In r/r MM At The EHA Virtual Congress